Correction to: Influence of CYP2C19 genotypes for the effect of 1 ‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT‑2
In the original publication of the article, Fig. 4(B) and 4(C) were published incorrectly. The correct figures are given in this correction.
Source: Cardiovascular Intervention and Therapeutics - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Genetics | Heart | Percutaneous Coronary Intervention | Plavix